Literature DB >> 27016186

[Sufentanil in combination with low-dose hyperbaric bupivacaine in spinal anesthesia for cesarean section: a randomized clinical trial].

Alexandre Dubeux Dourado1, Ruy Leite de Melo Lins Filho1, Raphaella Amanda Maria Leite Fernandes2, Marcelo Cavalcanti de Sá Gondim1, Emmanuel Victor Magalhães Nogueira3.   

Abstract

A double blind randomized clinical trial of sufentanil as an adjunct in spinal anesthesia for cesarean section and, thereby, be able to reduce the dose of bupivacaine, a local anesthetic, with the same result of an anesthetic block with higher doses but with fewer perioperative side effects, such as hypotension.
Copyright © 2016 Sociedade Brasileira de Anestesiologia. Publicado por Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Bupivacaine; Bupivacaína; Caesarean section; Cesariana; Hiperbárica; Hyperbaric; Raquianestesia; Spinal anesthesia; Sufentanil

Year:  2016        PMID: 27016186     DOI: 10.1016/j.bjan.2015.05.002

Source DB:  PubMed          Journal:  Rev Bras Anestesiol        ISSN: 0034-7094            Impact factor:   0.964


  4 in total

1.  Addition of low-dose sufentanil to ropivacaine for reducing shivering and visceral traction pain during cesarean section.

Authors:  Xiao-Rong Chen; Tao Gao; Yin Zhang; Ming-Qing Peng
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

2.  Sufentanil for Spinal Analgesia during Cesarean Section Delivery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Hongming Huang; Shiwu Wang; Rujun Lin; Zhongrun He
Journal:  Int J Clin Pract       Date:  2022-08-31       Impact factor: 3.149

3.  The Effect of Different Doses of Intrathecal Hyperbaric Bupivacaine Plus Sufentanil in Spinal Anesthesia for Cesarean Sections.

Authors:  Mahzad Alimian; Masood Mohseni; Seyed Hamid Reza Faiz; Alireza Rajabi
Journal:  Anesth Pain Med       Date:  2017-12-31

4.  Cross-sectional study on hearing loss and auditory reaction time before and after spinal anesthesia with marcaine 0.5% in patients undergoing elective surgery.

Authors:  Sepideh Vahabi; Parvin Veiskarami; Mehdi Roozbahani; Shahrzad Lashani; Behrouz Farzan
Journal:  Ann Med Surg (Lond)       Date:  2020-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.